Medical device maker Dexcom beat fourth-quarter sales estimates helped by resilient demand for its continuous glucose monitors (CGMs) used by patients with diabetes.
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of ...
We have excluded third-party attorney’s fees, costs, and expenses incurred by Dexcom exclusively in connection with Dexcom’s patent infringement litigation against Abbott Diabetes Care, Inc., as ...
The chemical compound sulforaphane found in broccoli sprouts can be linked to improved blood sugar levels in prediabetes, a ...
11h
GB News on MSNHigh blood sugar: 'I suffered from imbalanced glucose - the key signs showed up on my face'High blood sugar can show up in many different ways, and it’s not always easy to tell which symptoms require further ...
Today, Benzinga's options scanner identified 8 options transactions for DexCom. This is an unusual occurrence. The sentiment ...
Cover Media US on MSN17h
Diabetes: How to identify the warning signsNiamh McMillan, Superdrug's Pharmacy Superintendent, explains, “There are two main types of diabetes. Type 1 happens when a ...
Fast fashion creates mountains of polyester-cotton textile waste—a new recycling method that separates and recycles the two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results